BioMarin UK Limited
BMRN
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions.
Lobbying Activity
Meeting with Michael Mcnamara (Member of the European Parliament)
4 Feb 2025 · Technologies developed for rare diseases
Meeting with András Tivadar Kulja (Member of the European Parliament)
17 Oct 2024 · EU biotechnology
Meeting with Francesco Torselli (Member of the European Parliament)
15 Oct 2024 · Incontro conoscitivo per discutere delle nuove proposte regolatorie in tema di salute e malattie rare
Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)
8 Oct 2024 · New EU Pharmaceutical Legislation
Meeting with Billy Kelleher (Member of the European Parliament)
25 Sept 2024 · EU Health Policy
Meeting with Ondřej Knotek (Member of the European Parliament)
20 Mar 2024 · Pharmaceutical package
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)
15 Feb 2024 · Directive on Medicinal products for human use
Meeting with Billy Kelleher (Member of the European Parliament)
14 Feb 2024 · Pharmaceutical Strategy
Meeting with Deirdre Clune (Member of the European Parliament)
14 Feb 2024 · Pharmaceutical Package
Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)
6 Feb 2024 · Revision of the Pharmaceutical Legislation
Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur) and Edwards Lifesciences
30 Jan 2024 · Pharma legislation
Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and
18 Jul 2023 · Directive on Medicinal products for human use
Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and
7 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)
Meeting with Sirpa Pietikäinen (Member of the European Parliament)
30 Jan 2023 · EU’s action in the field of rare diseases
Meeting with Susana Solís Pérez (Member of the European Parliament, Shadow rapporteur) and ResMed
8 Nov 2022 · EHDS